[ANESTHETIC DRUGS IN CHILDREN AND PREGNANT WOMEN - IMPLICATIONS OF THE RECENT FDA WARNING]

Amit Lehavi1,2, Aeyal Raz1,3

  • 1Department of Anesthesiology, Rambam Healthcare Campus, Haifa, Israel.

Harefuah
|June 26, 2020
PubMed

Insights

Anesthetic drugs may harm developing brains, but human studies are inconclusive. Current evidence suggests single, short exposures are safe, but long-term effects require further research before changing clinical guidelines.

Area of Science:

  • Anesthesiology
  • Neuroscience
  • Developmental Pediatrics

Background:

  • Animal studies suggest early anesthetic exposure can cause neonatal neuronal damage with potential cognitive and social sequelae.
  • Human studies on anesthetic neurotoxicity in neonates, infants, and pregnant women have yielded inconclusive and often contradictory results.
  • Concerns about potential harm to the developing brain led to an FDA warning, but major European and Israeli anesthesiology societies have not adopted similar policies due to insufficient clinical evidence.

Purpose of the Study:

  • To evaluate the existing evidence regarding the neurotoxic potential of general anesthesia in developing brains.
  • To inform clinical practice and consent processes concerning anesthetic exposure in vulnerable populations.
  • To reconcile conflicting findings from animal and human studies on anesthetic neurotoxicity.

Main Methods:

  • Review of animal studies demonstrating neuronal apoptosis and damage after early anesthetic exposure.
  • Analysis of retrospective human studies, noting significant selection bias.
  • Evaluation of emerging prospective human studies on short, single anesthetic exposures.

Main Results:

  • While animal models show significant neurodevelopmental risks, human data remains inconclusive.
  • Retrospective studies are limited by confounding factors related to surgery and underlying conditions.
  • Preliminary results from high-quality prospective studies suggest that short, single anesthetic exposures may not cause measurable harm, pending long-term data.

Conclusions:

  • The clinical significance of anesthetic neurotoxicity in humans remains uncertain.
  • Major anesthesiology societies have opted against issuing warnings due to inconclusive evidence, to avoid delaying necessary procedures.
  • Further long-term research is needed to definitively assess the risks of general anesthesia on the developing brain in clinical settings.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
490
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
627
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
805
Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
681
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
479
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
778